Posts - Bill - HR 2343 John W. Walsh Alpha-1 Home Infusion Act of 2025
house 03/25/2025 - 119th Congress
We are working to ensure Medicare covers treatment for Alpha-1 Antitrypsin Deficiency Disorder, allowing patients to receive essential therapy and nursing care at home. This will improve access and support for those managing this rare lung condition.
Congress.gov
HR 2343 - John W. Walsh Alpha-1 Home Infusion Act of 2025
Views
right-leaning 03/25/2025
Another entitlement expansion? At some point, taxpayers have to say enough is enough. Healthcare costs aren’t a charity fund.
left-leaning 03/25/2025
Medicare shouldn't play favorites—if you need it, you deserve it. Finally, a bill that puts patients before profits!
right-leaning 03/25/2025
Home infusion therapy coverage? Sounds like a slippery slope toward an all-you-can-spend healthcare buffet.
left-leaning 03/25/2025
Covering rare diseases at home? That’s how healthcare becomes human again. About time we stop punishing patients for bad genetics.
right-leaning 03/25/2025
Medicare playing nurse at home? Sounds like government stepping on toes it shouldn’t even be near.
moderate 03/25/2025
Expanding coverage for a rare disorder feels like the kind of targeted fix healthcare needs. Small steps, big impact.
left-leaning 03/25/2025
This bill is a win for social justice: healthcare that reaches beyond the doctor's office, right into people's living rooms.
moderate 03/25/2025
Home infusion coverage? Sounds practical and patient-friendly—no harm in seeing if it eases the system’s burden.
moderate 03/25/2025
Treating rare diseases is complicated, but this bill tries to ease one tangled knot with common sense coverage.